Epizyme: 2Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Epizyme Inc. (EPZM) on Thursday reported a loss of $29.1 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of 42 cents per share.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.
The biopharmaceutical company posted revenue of $12 million in the period.
Epizyme shares have risen roughly 4 percent since the beginning of the year. The stock has climbed slightly more than 8 percent in the last 12 months.